Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Irini Zografaki, Marios Detsis, Maria Del Amo, Raffaella Iantomasi, Ana Maia, Eva Agostina Montuori & Cristina Mendez. (2023) Invasive meningococcal disease epidemiology and vaccination strategies in four Southern European countries: a review of the available data. Expert Review of Vaccines 22:1, pages 545-562.
Read now
Read now
Katherine A. Hicks, Parinaz Ghaswalla, Justin Carrico, Seri Anderson, Patricia Novy, Cosmina Hogea & Mary S. Hayney. (2023) Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States. Journal of American College Health 0:0, pages 1-10.
Read now
Read now
Woo-Yun Sohn, Halima Tahrat, Patricia Novy & Rafik Bekkat-Berkani. (2022) Real-world implementation of 4-component meningococcal serogroup B vaccine (4CMenB): implications for clinical practices. Expert Review of Vaccines 21:3, pages 325-335.
Read now
Read now
Eric Richardson, Kathleen A. Ryan, Robert M. Lawrence, Christopher A. Harle, Shivani M. Desai, Melvin D. Livingston, Amit Rawal & Stephanie A. S. Staras. (2021) Increasing awareness and uptake of the MenB vaccine on a large university campus. Human Vaccines & Immunotherapeutics 17:9, pages 3239-3246.
Read now
Read now
Justine Alderfer, Raul E. Isturiz & Amit Srivastava. (2020) Lessons from mass vaccination response to meningococcal B outbreaks at US universities. Postgraduate Medicine 132:7, pages 614-623.
Read now
Read now
Articles from other publishers (6)
Alexcia Carr, Eric Pittman, Hyllore Imeri, Saara Nasruddin, Wesley Sparkmon, Katharine J. Head, Sarah Vivo & Marie Barnard. (2022) Evaluation methods for vaccination campaigns on college campuses: A scoping review. Vaccine: X 12, pages 100226.
Crossref
Crossref
Gary S. Marshall, Jaime Fergie, Jessica Presa & Paula Peyrani. (2022) Rationale for the Development of a Pentavalent Meningococcal Vaccine: A US-Focused Review. Infectious Diseases and Therapy 11:3, pages 937-951.
Crossref
Crossref
Benjamin Faucher, Rania Assab, Jonathan Roux, Daniel Levy-Bruhl, Cécile Tran Kiem, Simon Cauchemez, Laura Zanetti, Vittoria Colizza, Pierre-Yves Boëlle & Chiara Poletto. (2022) Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nature Communications 13:1.
Crossref
Crossref
Lamine Soumahoro, Véronique Abitbol, Nevena Vicic, Rafik Bekkat-Berkani & Marco A. P. Safadi. (2021) Meningococcal Disease Outbreaks: A Moving Target and a Case for Routine Preventative Vaccination. Infectious Diseases and Therapy 10:4, pages 1949-1988.
Crossref
Crossref
Melanie J. Bernitz, Michael P. McNeil & Julie A. Casani. 2021. Principles and Practice of College Health. Principles and Practice of College Health
187
202
.
Cynthia Burman, Justine Alderfer & Vincenza T. Snow. (2019) A review of the immunogenicity, safety and current recommendations for the meningococcal serogroup B vaccine, MenB‐FHbp. Journal of Clinical Pharmacy and Therapeutics 45:2, pages 270-281.
Crossref
Crossref